Drug
Risperidone
Risperidone: highest development phase Phase 3, developed by Corcept Therapeutics, Dr. Reddy's, Indivior and others. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Corcept Therapeutics, Dr. Reddy's, Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| Risperidone NCT02717195 | Phase 3 | Schizophrenia |
| Risperidone NCT01677377 | Phase 2 | Schizophrenia |
| Risperidone NCT00698022 | Phase 1 | Healthy |
| Risperidone NCT01064271 | Phase 1 | Healthy |
Latest
No recent events.
Follow Risperidone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.